PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
There is an FDA-approved cannabis-based treatment for epilepsy [PMID:35991815]
Compounds extracted from hemp, particularly CBD, have shown anti-inflammatory and pain-relieving properties [PMID:42197253]
Hemp extracts have demonstrated neuroprotective, antioxidant, and antibacterial properties [PMID:42197253]
Cannabidiol (CBD) exerts potent anxiolytic, spasmolytic, and anticonvulsant effects [PMID:33614949]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 32906622 (2020) — Industrial Hemp (Cannabis sativa subsp. sativa) as an Emerging Source for Value-Added Functional Food Ingredients and Nutraceuticals. · Molecules (Basel, Switzerland)
- 2.PMID: 33673025 (2021) — Hemp-Based Microfluidics. · Micromachines
- 3.PMID: 39595380 (2024) — The Pharmacokinetics of Δ9-Tetrahydrocannabinol in Sheep. · Animals : an open access journal from MDPI
- 4.PMID: 35386746 (2022) — Review of nematode interactions with hemp (Cannabis sativa). · Journal of nematology
- 5.PMID: 33747008 (2021) — Medical Cannabis and Industrial Hemp Tissue Culture: Present Status and Future Potential.